3rd Annual Clinical Development And Outsourcing In Central And Eastern Europe - Conference This event is the only one which will examine in detail, the key regulatory, clinical, outsourcing, and environmental factors which impact the clinical trials landscape in specific locations in CEE. Particular and specific attention will be given to Russia and the Ukraine, the Balkan region, as well as Central European EU member states and even Turkey, via separate, focused, streamed conference sessions being run in parallel.
Source: www.medicalnewstoday.comPharmaceutical Pricing And Reimbursement In Central And Eastern Europe - Conference This event will present a fresh and original perspective on communicating the cost-effectiveness of high-value
drugs to key players and stakeholders in the former communistic countries of Central and Eastern Europe (CEE EU members, The Balkans and the former Soviet States). The conference will be unique because it will be specifically focus on pricing and reimbursement of high value
drugs in the CEE region.
Source: www.medicalnewstoday.comErythropoietins: The Shift From Biosimilars To 'more For Less' ESAs The Business Intelligence firm La Merie S.L. reported that for the first time sales of major erythropoietin products declined to US$ 11.8 bln in 2007, down by US$ 100 mln from the previous year. Additionally, four new epoetin based products were launched in European countries, among them two biosimilars, epoetin delta produced in a human cell line and Roche's pegylated version of epoetin beta.
Source: www.medicalnewstoday.comCartilage Repair Gel Under Development, Which Will Improve Quality Of Life For People Suffering With Medical Joint Trouble The University of Bradford's School of Engineering, Design and Technology and Advanced Gel Technology Ltd (AGT), a University spin-out company, are developing a cartilage repair gel to improve the quality of life for people suffering with medical joint trouble such as osteoarthritis.
Source: www.medicalnewstoday.com
# posted by Network @ 7:00 AM
